Open Menu
HOME
COMPANY
About us
PORIB team
Mission-Values
SERVICES
Health Economic Evaluation
Pricing and Reimbursement
Market Access
Real-World Evidence
Scientific Communication
Healthcare Management
Advisory Boards
Biostatistics
Training
CUSTOMERS
Pharmaceutical Industry
Scientific Societies
Universities and Training Schools
Other Collaborations
PUBLICATIONS
Therapeutic Area
Project Type
Papers
Abstracts
Books
TRAINING
BROCHURES
Corporate Brochure
Health Outcomes Research Brochure
Economic Evaluation Brochure
Statistical Evidence Brochure
en
es
Pharmacoeconomics & Outcomes Research Iberia
CONTACT
|
PORIB FOUNDATION
|
HOME
COMPANY
About us
PORIB team
Mission-Values
SERVICES
Health Economic Evaluation
Pricing and Reimbursement
Market Access
Real-World Evidence
Scientific Communication
Healthcare Management
Advisory Boards
Biostatistics
Training
CUSTOMERS
Pharmaceutical Industry
Scientific Societies
Universities and Training Schools
Other Collaborations
PUBLICATIONS
Therapeutic Area
Project Type
Papers
Abstracts
Books
TRAINING
BROCHURES
Corporate Brochure
Health Outcomes Research Brochure
Economic Evaluation Brochure
Statistical Evidence Brochure
en
es
Home
>
TRAINING
>
Training 2013
>
EM Forum. El Nuevo Paradigma de la Esclerosis Múltiple. Farmacoeconomía
EM Forum. El Nuevo Paradigma de la Esclerosis Múltiple. Farmacoeconomía
/
06 Sep 2013
Training 2013
EM Forum. El Nuevo Paradigma de la Esclerosis Múltiple. Farmacoeconomía
Septiembre 2013. Madrid
Previous Post
Introducción a la Evaluación Económica de Intervenciones Sanitarias en Nefrología
Next Post
Aula SEDAP (Sociedad Española de Directivos de la Salud). La Necesidad del Análisis de Resultados en Salud para el Empoderamiento de la Gestión Clínica